Global Contraceptive Pills Market (2018-2023) by Type, Category and Geography - ResearchAndMarkets.com

September 4, 2018

DUBLIN--(BUSINESS WIRE)--Sep 4, 2018--The “Global Contraceptive Pills Market - Segmented by Type, Category, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global contraceptive pills market was valued at around USD 1 billion in 2017 and is projected to witness a CAGR of approximately 9% during the forecast period of 2018-2023.

China, the world’s most populated country with a population of around 1.36 billion, has one of the highest rates of contraceptives usage.

Need to Prevent Unwanted Abortions

Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive pills to prevent this unwanted growth. It is estimated that among the number of pregnancies that occur in the United States, nearly 76% of them are unwanted and are under the age of 30.

According to Harvard researchers, it is estimated that single parenthood due to unwanted pregnancies is the reason for holding out on economic mobility, more than other variables like education and race.

Given the widespread implications of unwanted pregnancies, the market for contraceptive pills is expected to experience a surge during the forecast period. Also, other factors, like the ease of use of contraceptive pills and their low cost will drive the market.

Key Highlights

Limited Access to Contraception - Limiting Growth in Developing Nations United States Holds the Largest Market Share

Companies Profiled

Agile Therapeutics Bayer Healthcare Church & Dwight Co. Inc. Johnson & Johnson Ltd. Lupin Pharmaceuticals Ltd. Merck & Co. Mylan Laboratories Novartis Pfizer Teva Pharmaceuticals Ltd.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/6r69f9/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180904005480/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Women’s Health,Sexual and Reproductive Health Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/04/2018 08:40 AM/DISC: 09/04/2018 08:40 AM


Update hourly